Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillusand other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- Resource Type
- Article
- Source
- The Lancet; February 2016, Vol. 387 Issue: 10020 p760-769, 10p
- Subject
- Language
- ISSN
- 01406736; 1474547X